I guess you'll be writing this loss off for the next 50 years.

Wake up guys!!!! Your stock is running hard for the last week under the radar and it's starting to hit some alerts!

IFQJ is not one of these!!! This was mistakenly forwarded to me.

People BE CAREFUL!!! There is a group or an individual, waking up dead stocks with low or no float, and hoping MOMO players will jump on board and keep the pyramid going.

This one, SFTW, IFQJ, SPZN, FFPM to name a few are DEAD STOCKS.

The companies associated with them are all either bankrupt, out of business, or have merged and gone private. There may not even have legally tradable shares.

In my opinion, these tickers should have been delisted a long time ago, but there are alot of OTCBB and Pinkie shells lying around.

I started following this story a couple of weeks ago, and something very fishy is going on. I was open to all possibilities, but after a number of phone calls and returne emails, I am left with only one conclusion:

THIS IS A SHAMELESS PUMP AND DUMP OPERATION

Many people will be left holding the bag with these turds, and people are going to be hurt.

If you still have these shares in one of these pigs, your best chance is to hope that the MMs are short shares from the runup, and will have to cover before 30 days. You may get out, but with a 70% haircut, depending where you bought in the run

NO REAL COMPANY SHARES APPRECIATE 1000-9000% IN ONE DAY!

I wish I had better news on this, but I don't.

(I used to be a reporter, so I started following these stories to see if there was something more interesting about all these "zombie" stocks coming to life...perhaps fallout from RegSho. Sadly, there is nothing very interesting here...just plain old P&D.)

Lost $70 million in only 12 years of operation. This one of the worst run companies ever. The heads of this outfit took the money and ran. The gullible investors were all hammered on this scam.

Does anyone speak Japanese? I called the distributor number down there but there is only one guy there who speaks limited English. Please ask if they are still selling for Integrated Surgical Systems.

That spike fooled me, picked up 10000 shares of garbage. Has anyone bothered calling their contact numbers? No one ever picks up. Every single department in their directory connects to the same answering message. Called both contact numbers in Amsterdam and France and both of them are constantly busy. Did they go under and didn't bother to tell anyone?

I stayed in. I thought the spike was just too much for the news. It caught me off balance, and I could not see a clear path. By the time I thought about taking some profits, the price was already dropping, and I did not see a large enough profit to risk the potential future profits.

I watched my $100,000 plus turn into $50,000 plus, but it does not bother me. For once I am actually going to stay in for the long haul. With that said, it will be really difficult to hold all of my shares if it spikes again.

My current plan is to buy another 150,000 shares at or below .08. That will be my last large purchase. That would give me around 750,000 shares.

Then I will sit back and watch it grow (hopefully).

When it comes to RDOC, "I'm all in!"

Sorry it took so long to reply.

I guess that I honestly do not know enough about him to call it one way or the other. I would err on the side of the status quo simply because they have made it through some very tough times. I could only guess at what his role may have been in keeping the company alive, or what deals may have been made behind closed doors to substantiate such a large salary.

Regardless, I still have high hopes for this company, and I will be buying more shares in the next few months.

I would be interested to know why you have doubts about Ramesh. If you have the time please reply with more details.

I'm a fool too. Did you get out when the stock jumped to 22 cents?

I think something bigger than Fuji Film is about to happen.

I'm a long time holder of RDOC. I know the science is rock solid. However, I have a lot of doubt about Ramesh Trevedi. He draws a very large salary for the CEO of a company that has not been a business success. I voted against him in the last shareholders meeting but it looks like my opinion is a minority one. What do you and other's think of Mr. Ramesh?

WOW! This stock is really taking off. I made 50,000 paper dollars in two days.

Anyone know what is causing the sharp increase?

The Fuji deal may be the reason, but the volume is quite large.

Any other investors out there?

I've had this stock from the $1.25 TO $4.00 range and have lost any faith that this company can avoid bankruptcy. The clinical trials have been going on for over 2 years and have not been completed as far as anyone knows. Their balance sheets show very meager income and sales of only 1 or 2 units compared to the 30-40 units sold in the past. Their inventories are depleted and they owe significant amounts of money to their suppliers.

That all said and done, the technology and the concepts are fantastic, but it takes more than a good idea to become a success. If they don't go BK, I'd expect a huge dilution in share value due to the reissue or reverses split.

Call me a fool, but there is something about this company that I like. They have been working hard to reduce costs and open new markets. They are already an international company, and have begun the final phase of clinical trials in the US for the Robodoc system, a great product. Not to mention the fact that they have finally turned a profit. They have had positive earnings for the last two quarters, the first profit since their IPO. Tough times are still ahead, but they have shown that they have what it takes to fight through.

When I first began investing in RDOC I was playing with a few biotechs. I was making money, but did not like financing irresponsible science. I began looking for a small medical company that was innovative but still used tried and true scientific methods and technology. RDOC seemed to fit the bill, but had one small problem. Their Robodoc system was not approved in the US yet. I watched as the price dropped below a dollar and kept falling. I understood why, but that did not make it any easier to watch. It makes you wonder how so many harmful drugs get approved so quickly while a truly beneficial system like Robodoc is sitting in trials while the company fights for its life.

My father could have benefited greatly if Robodoc were available in the US. He has had 3 hip replacement surgeries, one of which almost killed him due to infection caused by poor fit. I can't even begin to tell you how much pain he has gone through. One leg is now longer than the other and he has to wear a special shoe to walk properly. When I read about the Robodoc procedure, I vowed to put as much money into this company as I could afford to lose.

To be completely forthcoming, I now own over 580,000 shares, which at 3 cents per share is currently only worth $15 thousand. I bought a bit around 8 cents and the rest at 3 cents.

The possibility of returns in this company are huge, if it reaches a dollar, my shares will be worth $580,000.00. If it goes under they'll be worth zero, but my gut tells me it won't. I have had total losses and large gainers in the past. This stock feels more like a winner.

I noticed that the volume shot up over a million shares with a rise in price a few days ago. Looks like someone is buying.

My strategy is to buy at 0.03 and hold. I will probably play the short term rises and drops with about 30 percent of my holding, and hold the rest for the long term.

I would like to hear others opinions about the future of the company, clinical trials, and investing strategies for RDOC.

Integrated Surgical Systems, Inc. Reaches An Agreement With Dr. Kenneth Krackow And Buffalo General Hospital/Kaleida Health To Be The Third Site For US FDA Mandated Clinical Trials For The ROBODOC Surgical Assistant System (The ROBODOC)

DAVIS, CA, Dec. 03, 2002 (INTERNET WIRE via COMTEX) -- Integrated Surgical Systems, Inc. (ISS) (OTCBB: RDOC), a pioneer in medical robotics and a leader in image-directed, semi-autonomous robotic products for surgical applications, announces that it has reached an agreement with Buffalo General Hospital/Kaleida Health and Dr. Kenneth Krackow for their participation as the third clinical site in the US FDA mandated Total Hip Arthroplasty (THA) procedure for the ROBODOC System.

Commenting on this agreement, Ramesh Trivedi, President and CEO of ISS, stated, "This is a very important step in our plan to complete the clinical trials as thoroughly and as rapidly as possible. To date, a total of 89 patients have either already undergone the surgeries or are waiting to be operated as a part of the current clinical studies. With other clinical sites on the West Coast, in the Southwest, we were looking for a highly reputable site on the East Coast."

"Dr. Krackow's familiarity with the ROBODOC system goes back several years. He played a key role in helping ISS develop the Total Knee Arthroplasty procedure for the ROBODOC system, which has been commercially available outside of the USA since 2000. His reputation as the premier orthopedic surgeon throughout the world, combined with his keen interest in the robotics technology, made him the ideal choice. We are very honored that Dr. Krackow has agreed to participate in this study."

"Ever since I collaborated with ISS in advising and guiding them through the development of ROBODOC TKA procedure, I have been very intrigued and impressed with the robotics technology and its potential in the orthopedic surgeries. Participation in the clinical trials seemed like an excellent way to further involve myself, my staff and the institution with this technology," commented Dr. Krackow.

Integrated Surgical Systems designs, manufactures, sells and services image-directed, computer-controlled robotic products for use in orthopedic and neurosurgical procedures. Our ROBODOC(R) Surgical Assistant System is the world's leading robotic system for hip and knee replacement surgery. NeuroMate, our neurosurgery system, is the first robotic technology-based system for use in stereotactic brain surgery.

Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties, including the timely development and market acceptance of new products and upgrades to existing products, the impact of competitive products and pricing, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission (SEC).

ROBODOC(R) is a registered trademark of Integrated Surgical Systems, Inc.

NeuroMate(TM) is a trademark of Integrated Surgical Systems, S.A.

http://www.robodoc.com

CONTACT:
Ramesh C. Trivedi, Ph.D.
President and CEO
Integrated Surgical Systems
530-792-2600
Charles Novak
CFO
Integrated Surgical Systems
530-792-2600

.